Top

Journal of Cancer Survivorship

Published in:

Open Access 01-03-2010

Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors

Authors: Catherine M. Crespi, Sophia K. Smith, Laura Petersen, Sheryl Zimmerman, Patricia A. Ganz

Published in: Journal of Cancer Survivorship | Issue 1/2010

Abstract

Introduction

Self-report instruments such as the Impact of Cancer (IOC) are designed to measure quality of life (QOL) impacts that cancer survivors attribute to their cancer experience. Generalizability of QOL findings across distinct diagnostic categories of survivors is untested. We compare measurement of the impact of cancer using the IOC instrument in breast cancer (BC) survivors (n = 1,188) and non-Hodgkin lymphoma (NHL) survivors (n = 652).

Methods

A registry-based sample of NHL survivors completed the IOC questionnaire and the FACT-G, FACT-LYM, Medical Outcomes Study (MOS) SF-36, Post-Traumatic Stress Disorder Checklist-Civilian Version, Post-Traumatic Growth Inventory and MOS Social Support scales. IOC responses of the NHL survivors were subjected to de novo scaling to identify impact domains for comparison to IOC version 2 (IOCv2) domains, which were previously developed based on BC survivor responses. Concurrent validity was assessed by correlating the IOCv2 scales with the other measures. IOCv2 scores were compared between the BC and NHL survivor samples.

Results

The BC and NHL survivors exhibited similar impact domains and had factor structures that were largely congruent. The concurrent validity analysis revealed patterns of association that supported the interpretation and validity of the IOCv2 scales. Differences in IOCv2 scores between the BC and NHL groups suggested differential impacts in distinct survivor groups that could be detected using the IOCv2.

Conclusion

The results suggest that the IOCv2 measures common and important survivor concerns and support its generalizability to the broader long-term cancer survivor population.

Implications for Cancer Survivors

Instruments such as the IOCv2 can provide valid assessment of QOL impacts in long-term cancer survivors, facilitating the characterization of these impacts and development of appropriate interventions.

Available only for authorised users

Ries LAG, Melbert D, Krapcho M et al (eds). SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site, accessed March 2009.

Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst. 1998;90:656–67.CrossRefPubMed

Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007;16:691–706.CrossRefPubMed

Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12:432–43.CrossRefPubMed

Aziz NM. Late effects of cancer treatment. In: Chang AE, Ganz PA, Hayes DF, et al., editors. Oncology: an evidence-based approach. New York: Springer; 2006. p. 1768–90.

Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncologica. 2007;46:417–32.CrossRefPubMed

Hewitt M, Greenfield S, Stovall E (eds). From cancer patient to cancer survivor: lost in transition. The National Academies Press, 2006.

Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25.CrossRefPubMed

Noorda EM, van Kreij RHJ, Vrouenraets BC, Nieweg OE, Muller M, Kroon BBR, et al. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol. 2007;33(6):776–82.PubMed

10.

Hodgkinson K, Butow P, Fuchs A, Hunt GE, Stenlake A, Hobbs KM, et al. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecologic Oncol. 2007;104(2):381–9.CrossRef

11.

Weaver KE, Llabre MM, Lechner SC, Penedo F, Antoni MH. Comparing unidimensional and multidimensional models of benefit finding in breast and prostate cancer. Qual Life Res. 2008;17:771–81.CrossRefPubMed

12.

Mols F, Vingerhoets AJJM, Coebergh JWW, van de Poll-Franse LV. Well-being, postraumatic growth and benefit finding in long-term breast cancer survivors. Psychology & Health. 2009;24:583–95.CrossRef

13.

Porter LS, Clayton MF, Belyea M, Mishel M, Gil KM, Germino BB. Predicting negative mood state and personal growth in African American and white long-term breast cancer survivors. Ann Behav Med. 2006;31:195–204.CrossRefPubMed

14.

Foley KL, Farmer DF, Petronis VM, Smith RG, McGraw S, Smith K, et al. A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology. 2006;15(3):248–58.CrossRefPubMed

15.

Bower JE, Meyerowitz BE, Desmond KA, Bernaards CA, Rowland JH, Ganz PA. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann Behav Med. 2005;29:236–45.CrossRefPubMed

16.

Bellizzi KM, Miller MF, Arora NK, Rowland JH. Positive and negative life changes experienced by survivors of non-Hodgkin's lymphoma. Ann Behav Med. 2007;34:188–99.CrossRefPubMed

17.

Ferrell BR, Hassey Dow K, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4:523–31.CrossRefPubMed

18.

Wyatt GKH, Friedman LL. Development and testing of a quality of life model for long-term female cancer survivors. Qual Life Res. 1996;5:387–94.CrossRefPubMed

19.

Avis NE, Smith KW, McGraw S, et al. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14:1007–23.CrossRefPubMed

20.

Avis NE, Ip E, Foley KL. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes. 2006;4:92–102.CrossRefPubMed

21.

Ferrell BR, Hassey Dow K, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4:523–31.CrossRefPubMed

22.

Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14:1007–23.CrossRefPubMed

23.

24.

Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B. Base-line quality-of-life assessment in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst. 1995;87:1372–82.CrossRefPubMed

25.

Stanton AL, Bernaards CA, Ganz PA. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst. 2005;97:448–56.PubMedCrossRef

26.

Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6:95–105.CrossRefPubMed

27.

Gotay CC, Pagano IS. Assessment of survivor concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5:15–25.CrossRefPubMed

28.

Zebrack BJ, Ganz PA, Bernaards CA, et al. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncol. 2006;15:407–21.CrossRef

29.

Zebrack BJ, Yi J, Petersen L, Ganz PA. The impact of cancer and quality of life for long-term survivors. Psychooncol. 2008;17:891–900.CrossRef

30.

Crespi CM, Ganz PA, Petersen L, et al. Refinement of the Impact of Cancer (IOC) scale in a sample of long-term breast cancer survivors. J Natl Cancer Inst. 2008;100:1530–41.CrossRefPubMed

31.

Bower JE, Meyerowitz BE, Desmond KA, et al. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann Behav Med. 2005;29:236–45.CrossRefPubMed

32.

Bellizzi KM, Miller MF, Arora NK, et al. Positive and negative life changes experienced by survivors of non-Hodgkin's lymphoma. Ann Behav Med. 2007;34:188–99.CrossRefPubMed

33.

Hodgkinson K, Butow P, Fuchs A, et al. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecologic Oncol. 2007;104:381–9.CrossRef

34.

Smith SK, Zimmerman S, Williams CS, et al. Post-traumatic stress outcomes in non-Hodgkin’s lymphoma survivors. J Clin Oncol. 2008;26:934–41.CrossRefPubMed

35.

Caan B, Sternfeld B, Gunderson E, et al. Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005;16:545–56.CrossRefPubMed

36.

Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.PubMed

37.

Cella D, Webster K, Cashy J, et al. Development of a measure of health-related quality of life for non-Hodgkin's lymphoma clinical research: The functional assessment of cancer therapy—Lymphoma (FACT-Lym). Blood. 2005;106:222A. abstract.

38.

Ware JE. 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Medical Care. 1992;30:473–83.CrossRefPubMed

39.

American Psychiatric Association. Diagnostic and statistical manual. 4th ed. Washington: American Psychiatric Association; 1994.

40.

Weathers FW, Litz B, Herman D, et al. The PTSD Checklist (PCL-C): Reliability, validity and diagnostic utility. Presented at the 9th Annual Meeting of the International Society for Traumatic Stress Studies, San Antonio, TX, October 24–27, 1993 (abstract).

41.

Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Traum Stress. 1996;9:455–71.CrossRef

42.

Taku K, Cann A, Calhoun LG, et al. The factor structure of the posttraumatic growth inventory: a comparison of five models using confirmatory factor analysis. J Traum Stress. 2008;21:158–64.CrossRef

43.

Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705–14.CrossRefPubMed

44.

McCrae RR, Zonderman AB, Costa PT, et al. Evaluating replicability of factors in the revised NEO personality inventory: confirmatory factor analysis versus procrustes rotation. J Pers Soc Psychol. 1996;70:552–66.CrossRef

45.

Kaiser HF, Hunka S, Bianchini JC. Relating factors between studies based upon different individuals. Multivariate Behav Res. 1971;6:409–22.CrossRef

46.

Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for ‘quantitative significance’ in statistical decisions. J Clin Epidemiol. 1990;43:1273–84.CrossRefPubMed

47.

Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16:297–334.CrossRef

48.

Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.

49.

Helmstadter GC. Principles of psychological measurement. New York: Appleton-Century-Crofts; 1964.

50.

Tedeschi RG, Park CL, Calhoun LG. Posttraumatic growth: positive changes in the aftermath of crisis. Mahwah: Lawrence Erlbaum Associates; 1998. p. 258.

51.

Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial conmcerns and quality of life. Breast Cancer Res Treat. 1996;38:183–99.CrossRefPubMed

52.

Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks P, Bloom JR. Body image and sexual problems in young women with breast cancer. Psychooncol. 2006;15:579–94.CrossRef

53.

Dany L, Apostolidis T, Cannone P, Suarez-Diaz E, Filipetto F. Body image and cancer: a psychosocial analysis. Psycho-Oncologie. 2009;3:101–17.CrossRef

54.

Harrington JM, Jones EG, Badger T. Body image perceptions in men with prostate cancer. Oncol Nurs Forum. 2009;36:167–72.CrossRefPubMed

55.

Reimers TS, Mortensen EL, Nysom K, Schmiegelow K. Health-related quality of life in long-term survivors of childhood brain tumors. Pediatric Blood Cancer. 2009;53:1086–91.CrossRefPubMed

56.

Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Comprehensive Cancer Network. 2009;8:883–93.

57.

Jim HSL, Jacobsen. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer Journal. 2008;14:414–9.CrossRef

Title: Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
Authors: Catherine M. Crespi
Sophia K. Smith
Laura Petersen
Sheryl Zimmerman
Patricia A. Ganz
Publication date: 01-03-2010
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 1/2010
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-009-0106-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 1/2010

The role of occupational upper extremity use in breast cancer related upper extremity lymphedema

Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer

Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS)

Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey

Surveillance mammography for Medicaid/Medicare breast cancer patients

Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer